Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCARF-1
NCT07029503Phase 2Recruiting
- Sponsor
- Karolinska Institutet
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of eplerenone in heart failure with reduced ejection fraction (HFrEF), chronic kidney disease (CKD), sponsored by Karolinska Institutet. Started Feb 2026; status: recruiting.
02
Drugs
eplerenone
03
Conditions
heart failure with reduced ejection fraction (HFrEF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07029503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07029503.